NCT00161785View on ClinicalTrials.gov

Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years

PHASE4CompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

July 31, 2005

Conditions
Tick-borne Encephalitis
Interventions
BIOLOGICAL

FSME-IMMUN 0.5ml

Trial Locations (2)

33-200

Hospital in Debica - Zespo Opieki Zdrowotnej w Debicy, Dębica

31-202

Szpital Jana Pawla II Oddzial Neuroinfekcji, Krakow

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY